Farringdon Capital’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-17,152
Closed -$329K 615
2024
Q4
$329K Buy
+17,152
New +$329K 0.14% 246